Flu vaccine strategy on the line as new US leaders anticipated to take charge
As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines could be due…
Infectious Disease
-
-
Better prevention and treatment options needed for genital herpes, WHO says
A World Health Organization (WHO) director has called for “better prevention and treatment options” after the agency released new estimates…
-
PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amass
Research activity in the human immunodeficiency viruses space (HIV) is pivoting towards pre-exposure prophylaxis (PrEP) therapies as vaccine failures rack…
-
Oxford Nanopore and UK to develop pathogen surveillance system
Oxford Nanopore has entered a strategic partnership with the UK Government to create a pathogen surveillance system in the National…
-
Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
Matinas BioPharma has halted all product development activities and fired 80% of its staff, including three members of senior management,…
-
Spero’s stock slides after antibiotic flops in Phase II trial
Spero Therapeutics has suspended the development of its antibiotic SPR720, after the therapy failed to meet the primary endpoint in a Phase…
-
Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase II trial
Bavarian Nordic is looking to expand the approval label of its MVA-BN mpox/smallpox vaccine to include children two to 11…
-
US CDC AdCom recommends lowering the age for pneumococcal vaccines
A US Centers for Disease Control and Prevention’s (CDC) Advisory Committee (AdCom) on Immunization Practice (ACIP) voted in favour of…
-
FDA expands Pfizer’s RSV vaccine label to include all high-risk adults
The US Food and Drug Administration (FDA) has expanded the indication for Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo to…
-
MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win
MSD (Merck & Co) is planning to get its respiratory syncytial virus (RSV) vaccine, clesrovimab, approved and launched before the…
